Literature DB >> 24715532

Chronic disease burden among cancer survivors in the California Behavioral Risk Factor Surveillance System, 2009-2010.

Heather P Tarleton1, Suzanne Ryan-Ibarra, Marta Induni.   

Abstract

PURPOSE: The California Behavioral Risk Factor Surveillance System estimates that 56.6 % of cancer survivors report ever being diagnosed with a chronic disease. Few studies have assessed potential variability in comorbidity by cancer type.
METHODS: We used data collected from a representative sample of adult participants in the 2009 and 2010 California Behavioral Risk Factor Surveillance System (n = 18,807). Chronic diseases were examined with cancer survivorship in case/non-case and case/case analyses. Prevalence ratios (PR) and corresponding 95 % confidence intervals (95 % CI) were estimated using Cox proportional hazards models, with adjustment on race, sex, age, education, smoking, and drinking.
RESULTS: Obesity was associated with gynecological cancers (PR 1.74; 95 % CI 1.26-2.41), and being overweight was associated with gynecological (PR 1.40; 95 % CI 1.05-1.86) and urinary (PR 2.19; 95 % CI 1.21-3.95) cancers. Arthritis was associated with infection-related (PR 1.78; 95 % CI 1.12-2.83) and hormone-related (PR 1.20; 95 % CI 1.01-1.42) cancers. Asthma was associated with infection- (PR 2.26; 95 % CI 1.49-3.43), hormone- (PR 1.46; 95 % CI 1.21-1.77), and tobacco- (PR 1.86; 95 % CI 1.25-2.77) related cancers. Chronic obstructive pulmonary disease (COPD) was associated with infection- (PR 2.16; 95 % CI 1.22-3.83) and tobacco-related (PR 2.24; 95 % CI 1.37-3.66) cancers and with gynecological cancers (PR 1.60; 95 % 1.00-2.56).
CONCLUSIONS: This is the first study to examine chronic disease burden among cancer survivors in California. Our findings suggest that the chronic disease burden varies by cancer etiology. IMPLICATIONS FOR CANCER SURVIVORS: A clear need has emerged for future biological and epidemiological studies of the interaction between chronic disease and cancer etiology in survivors.

Entities:  

Mesh:

Year:  2014        PMID: 24715532     DOI: 10.1007/s11764-014-0350-x

Source DB:  PubMed          Journal:  J Cancer Surviv        ISSN: 1932-2259            Impact factor:   4.442


  90 in total

1.  Looking beyond recurrence: comorbidities in cancer survivors.

Authors:  Amy Edgington; Mary Ann Morgan
Journal:  Clin J Oncol Nurs       Date:  2011-02       Impact factor: 1.027

Review 2.  Primary care management of chronic obstructive pulmonary disease to reduce exacerbations and their consequences.

Authors:  Antonio Anzueto
Journal:  Am J Med Sci       Date:  2010-10       Impact factor: 2.378

3.  Pedometer-determined physical activity is linked to low systemic inflammation and low arterial stiffness in Type 2 diabetes.

Authors:  P Jennersjö; J Ludvigsson; T Länne; F H Nystrom; J Ernerudh; C J Östgren
Journal:  Diabet Med       Date:  2012-09       Impact factor: 4.359

4.  A case-control study of asthma and ovarian cancer.

Authors:  Wafic M Elmasri; Therese H Tran; Zuber D Mulla
Journal:  Arch Environ Occup Health       Date:  2010 Apr-Jun       Impact factor: 1.663

5.  History of asthma or eczema and cancer risk among men: a population-based case-control study in Montreal, Quebec, Canada.

Authors:  Mariam El-Zein; Marie-Elise Parent; Khady Kâ; Jack Siemiatycki; Yves St-Pierre; Marie-Claude Rousseau
Journal:  Ann Allergy Asthma Immunol       Date:  2010-05       Impact factor: 6.347

6.  Risk of cancer among rheumatoid arthritis patients in California.

Authors:  Arti Parikh-Patel; Richard H White; Mark Allen; Rosemary Cress
Journal:  Cancer Causes Control       Date:  2009-01-28       Impact factor: 2.506

7.  Objectively measured physical activity and sedentary time of breast cancer survivors, and associations with adiposity: findings from NHANES (2003-2006).

Authors:  Brigid M Lynch; David W Dunstan; Genevieve N Healy; Elisabeth Winkler; Elizabeth Eakin; Neville Owen
Journal:  Cancer Causes Control       Date:  2009-11-01       Impact factor: 2.506

Review 8.  Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship.

Authors:  Amanda Nickles Fader; Lucybeth Nieves Arriba; Heidi E Frasure; Vivian E von Gruenigen
Journal:  Gynecol Oncol       Date:  2009-04-29       Impact factor: 5.482

9.  Risk of development of lung cancer is increased in patients with rheumatoid arthritis: a large case control study in US veterans.

Authors:  Ritu Khurana; Robert Wolf; Steven Berney; Gloria Caldito; Samina Hayat; Seth Mark Berney
Journal:  J Rheumatol       Date:  2008-07-15       Impact factor: 4.666

Review 10.  Survivorship: adult cancer survivors.

Authors:  Patricia A Ganz
Journal:  Prim Care       Date:  2009-12       Impact factor: 2.907

View more
  4 in total

1.  Receipt of a survivorship care plan and self-reported health behaviors among cancer survivors.

Authors:  L Aubree Shay; Susanne Schmidt; Shayda I Dioun; Allison Grimes; Leanne Embry
Journal:  J Cancer Surviv       Date:  2019-02-14       Impact factor: 4.442

2.  Utah Cancer Survivors: A Comprehensive Comparison of Health-Related Outcomes Between Survivors and Individuals Without a History of Cancer.

Authors:  Brynn Fowler; Qian Ding; Lisa Pappas; Yelena P Wu; Lauri Linder; Jeff Yancey; Jennifer Wright; Margaret Clayton; Deanna Kepka; Anne C Kirchhoff
Journal:  J Cancer Educ       Date:  2018-02       Impact factor: 2.037

3.  Combined aerobic and resistance training improves bone health of female cancer survivors.

Authors:  Hawley C Almstedt; Silvie Grote; Joshua R Korte; Stephanie Perez Beaudion; Todd C Shoepe; Sarah Strand; Heather P Tarleton
Journal:  Bone Rep       Date:  2016-09-21

4.  Arterial elasticity as a risk factor for early cardiovascular disease among testicular cancer survivors treated with platinum-based chemotherapy: a cross-sectional pilot study.

Authors:  Anne H Blaes; Daniel A Mulrooney; Rachel Isaksson Vogel; Anna Solovey; Robert Hebbel; Bruce A Peterson; Joseph P Neglia; Carter Biewen; Suma H Konety; Daniel A Duprez
Journal:  Vasc Health Risk Manag       Date:  2018-09-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.